MICHAEL FRUMOVITZ to Response Evaluation Criteria in Solid Tumors
This is a "connection" page, showing publications MICHAEL FRUMOVITZ has written about Response Evaluation Criteria in Solid Tumors.
Connection Strength
0.212
-
Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract. Gynecol Oncol. 2020 09; 158(3):570-575.
Score: 0.172
-
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor. Gynecol Oncol. 2019 06; 153(3):541-548.
Score: 0.040